The pro-inflammatory cytokine IL6 suppresses mitochondrial function via the gp130-JAK1/STAT1/3-HIF1α/ERRα axis
Chronic inflammation and a decline in mitochondrial function are hallmarks of aging. Here, we show that the two mechanisms may be linked. We found that interleukin-6 (IL6) suppresses mitochondrial function in settings where PGC1 (both PGC1α and PGC1β) expression is low. This suppression is mediated by the JAK1/STAT1/3 axis, which activates HIF1α through non-canonical mechanisms involving upregulation of HIF1A and ERRα transcription, and subsequent stabilization of the HIF1A protein by ERRα. HIF1α, in turn, inhibits ERRα, which is a master regulator of mitochondrial biogenesis, thus contributing to the inhibition of mitochondrial function. When expressed at higher levels, PGC1 rescues ERRα to boost baseline mitochondrial respiration, including under IL6-treated conditions. Our study suggests that inhibition of the IL6 signaling axis could be a potential treatment for those inflammatory settings where mitochondrial function is compromised.
Authors
- Yanfeng Yang
- Matthew Wakai
- Diana Ahrens
- Jianing Xu (ORCID: https://orcid.org/0000-0003-2547-4344)
- Maria del Pilar Molina‐Portela
- David J. Glass (ORCID: https://orcid.org/0000-0001-6187-4164)
- Yu Bai (ORCID: https://orcid.org/0000-0002-0371-8590)
- Kun Xiong (ORCID: https://orcid.org/0000-0002-3918-9782)
- Min Ni (ORCID: https://orcid.org/0000-0001-6382-0848)
- Tea Shavlakadze
- Sophia P. Wu
- Adithya Prabakaran
Institutions
- Regeneron (United States) (US)
Publication Details
- Journal
- Cell Reports
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.celrep.2025.115403
- Citations
- 11
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 11.50
Funders
- Regeneron Pharmaceuticals